Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sage Therapeutic Com (SAGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Sage Therapeutics Submits New Drug Application to U.S. FDA for Intravenous Brexanolone in the Treatment of Postpartum Depression

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the...

SAGE : 143.66 (+2.35%)
Watch for Sage Therapeutic to Potentially Rebound After Falling 9.69% Yesterday

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $150.23 to a high of $168.53. Yesterday, the shares fell 9.7%, which took the trading range below the 3-day low of...

SAGE : 143.66 (+2.35%)
Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

Style Box ETF report for VTWG

IWO : 192.86 (+0.67%)
EXAS : 46.60 (+2.94%)
VTWG : 140.35 (+0.94%)
SAGE : 143.66 (+2.35%)
VBK : 165.84 (+0.89%)
NKTR : 84.19 (+1.94%)
Relatively Good Performance Detected in Shares of Atara Biotherape in the Biotechnology Industry (ATRA , EPZM , SAGE , LOXO , ONCE )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

SAGE : 143.66 (+2.35%)
ATRA : 42.50 (+4.42%)
EPZM : 13.40 (-0.37%)
Spark Therapeuti is Among the Companies in the Biotechnology Industry with the Best Relative Performance (ONCE , SAGE , IRWD , AGIO , EXAS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

IRWD : 17.44 (+2.89%)
ONCE : 77.12 (+4.46%)
SAGE : 143.66 (+2.35%)
FDA Refuses Alkermes Depression Drug Review: 4 Stocks in Focus

The FDA's refusal to review Alkermes' depression candidate AKLS 5461 has brought depression disease market in focus. Here we take a look at a few companies developing products for this market.

JNJ : 128.01 (+0.99%)
LLY : 82.55 (+1.74%)
AGN : 160.53 (+2.17%)
SAGE : 143.66 (+2.35%)
ALKS : 46.05 (+4.49%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that,...

SAGE : 143.66 (+2.35%)
Look for Shares of Sage Therapeutic to Potentially Rebound after Yesterday's 1.43% Sell Off

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $142.39 to a high of $150.82. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

SAGE : 143.66 (+2.35%)
Sage Therapeutic Set to Possibly Rebound After Yesterday's Selloff of 1.03%

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $170.26 to a high of $174.74. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of...

SAGE : 143.66 (+2.35%)
Pre-Market Technical Scan on Biotech Equities -- Riot Blockchain, Sage Therapeutics, Sarepta Therapeutics, and Sierra Oncology

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on RIOT, SAGE, SRPT, and SRRA which can be accessed for free by signing up to www.wallstequities.com/registration....

SRPT : 78.95 (+1.48%)
SRRA : 1.95 (+6.56%)
RIOT : 7.47 (+1.49%)
SAGE : 143.66 (+2.35%)
3 Small-Cap ETFs Experiencing High Inflows

U.S. small cap ETFs witness high inflows, as current market scenario increases appeal of domestic businesses.

SPSM : 30.52 (+0.43%)
SPR : 80.00 (+1.45%)
FANG : 126.87 (+0.89%)
BLUE : 170.45 (+4.83%)
GRUB : 98.53 (+3.10%)
SAGE : 143.66 (+2.35%)
VB : 148.97 (+0.45%)
SPY : 266.31 (+1.02%)
SCHA : 70.28 (+0.46%)
NKTR : 84.19 (+1.94%)
3 Small-Cap ETFs Experiencing High Inflows

U.S. small cap ETFs witness high inflows, as current market scenario increases appeal of domestic businesses.

SPSM : 30.52 (+0.43%)
SPR : 80.00 (+1.45%)
FANG : 126.87 (+0.89%)
BLUE : 170.45 (+4.83%)
GRUB : 98.53 (+3.10%)
SAGE : 143.66 (+2.35%)
VB : 148.97 (+0.45%)
SPY : 266.31 (+1.02%)
SCHA : 70.28 (+0.46%)
NKTR : 84.19 (+1.94%)
SmarTrend Watching for Potential Pullback in Shares of Sage Therapeutic After 2.96% Gain

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $162.32 to a high of $168.67. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

SAGE : 143.66 (+2.35%)
Today's Research Reports on Trending Tickers: Sage Therapeutics and ACADIA Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / February 26, 2018 / U.S. market rallied on Friday as investors awaited an update on interest rates from the Federal Reserve. The Dow Jones Industrial Average was up by 1.39...

SAGE : 143.66 (+2.35%)
ACAD : 15.12 (-0.53%)
SAGE Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 22, 2018 / SAGE Therapeutics, Inc. (NASDAQ: SAGE) will be discussing their earnings results in their Q4 Earnings Call to be held on February 22, 2018 at 8:00 AM Eastern...

SAGE : 143.66 (+2.35%)
Sage Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Pipeline Update

--Breakthrough Therapy designation for SAGE-217 offers potential for expedited development of major depressive disorder program

SAGE : 143.66 (+2.35%)
Sage Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, February 22, 2018

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that...

SAGE : 143.66 (+2.35%)
Today's Research Reports on Stocks to Watch: Sarepta Therapeutics and Sage Therapeutics

NEW YORK, NY / ACCESSWIRE / February 12, 2018 / Sarepta shares closed in the red on Friday after the company's Essence study was halted in the U.K. Shares of Sage Therapeutics also closed down after announcing...

SRPT : 78.95 (+1.48%)
SAGE : 143.66 (+2.35%)
Stock Review for Biotech's Investors -- Sage Therapeutics, Sarepta Therapeutics, Sierra Oncology, and Sorrento Therapeutics

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on SAGE, SRPT, SRRA, and SRNE which can be accessed for free by signing up to www.wallstequities.com/registration....

SRNE : 6.25 (+2.46%)
SRPT : 78.95 (+1.48%)
SRRA : 1.95 (+6.56%)
SAGE : 143.66 (+2.35%)
Sage Therapeutics Prices Public Offering of Common Stock

Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the pricing...

JPM : 110.10 (+0.10%)
SAGE : 143.66 (+2.35%)

Van Meerten Stock Picks

5 Great Mid Caps
This morning I wanted to find the Mid Cap stocks that not only had some of the best returns in the past 12 months but still seemed to have some upside potential.
IBKR +1.69 , HFC +2.48 , ABMD +10.21 , CAR +0.50 , URBN +0.42
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures saw fractional to penny losses in most contracts on Thursday. The USDA reported a private export sale of 107,600 MT of corn for 17/18 delivery to unknown destinations this morning. The Export Sales report, however, indicated that just 69...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar